Akums Drugs and Pharmaceuticals balance sheet

As of Mar 2026

Total assets: ₹5,447cr+32.4% on Mar 2025
Shareholders' equity: ₹3,331cr+8.7% on Mar 2025
Total debt: ₹73.0cr+434.3% on Mar 2025
Cash and investments: ₹386cr+281.5% on Mar 2025

₹ crore except per share

Tap a line for its trend	FY26Mar 2026	FY25Mar 2025

Non-current assets
	1,448	1,390
	177	160
	2.1	2.1
	5.5	5.1
	0.7	3.2
	0.1	0.1
	29.3	33.6
	29.5	33.7
	171	208
	53.6	36.9
	1,887	1,839
Current assets
	756	681
	797	770
	386	101
	1,295	475
	29.6	48.1
	2,507	1,395
	297	199
	3,560	2,275
	5,447	4,113
Equity
	30.6	30.6
	3,283	3,016
	3,313	3,047
	17.8	16.6
	3,331	3,064
Liabilities
	114	34.2
	114	34.2
	48.6	35.9
	17.7	18.6
	841	67.3
	1,021	156
	73.0	13.7
	602	643
	141	141
	816	797
	65.4	57.2
	8.9	0.4
	204	39.1
	1,095	894
	2,116	1,050
	5,447	4,113
Trade payables — MSME split
	88.0	77.2
	514	566

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

AKUMS₹741.05

Akums Drugs and Pharmaceuticals Ltd.

· Pharma & Health

₹ CrorePeersALIVUS AGARWALEYE ADVENZYMES APLLTD AARTIPHARM AARTIDRUGS CORONA HCGMcap ₹11,346 Cr

View

In ₹ Crore except Per Share As of	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Non-current Assets
+ Property, Plant & Equipment	1,390.2	1,448.3	1,448.3
+ Capital Work-in-Progress	159.6	176.7	176.7
+ Goodwill	2.1	2.1	2.1
+ Other Intangibles	5.1	5.5	5.5
+ Intangibles under Development	3.2	0.7	0.7
+ Non-current Investments	0.1	0.1	0.1
+ Other Non-current Financial Assets	33.6	29.3	29.3
Non-current Financial Assets	33.7	29.5	29.5
+ Deferred Tax Assets	208.1	170.9	170.9
+ Other Non-current Assets	36.9	53.6	53.6
Total Non-current Assets	1,838.8	1,887.1	1,887.1
Current Assets
+ Inventories	680.9	755.7	755.7
+ Trade Receivables	770.3	796.6	796.6
+ Cash & Cash Equivalents	101.2	386.0	386.0
+ Other Bank Balances	475.3	1,294.6	1,294.6
+ Other Current Financial Assets	48.1	29.6	29.6
Current Financial Assets	1,394.9	2,506.7	2,506.7
+ Other Current Assets	198.8	297.4	297.4
Total Current Assets	2,274.6	3,559.9	3,559.9
Total Assets	4,113.4	5,447.0	5,447.0
Equity
+ Equity Share Capital	30.6	30.6	30.6
+ Other Equity / Reserves	3,016.4	3,282.7	3,282.7
Equity — Owners of Parent	3,047.0	3,313.3	3,313.3
+ Minority Interest	16.6	17.8	17.8
Total Equity	3,063.6	3,331.1	3,331.1
Liabilities
+ Other Non-current Financial Liab	34.2	114.0	114.0
Non-current Financial Liabilities	34.2	114.0	114.0
+ Provisions — Non-current	35.9	48.6	48.6
+ Deferred Tax Liabilities	18.6	17.7	17.7
+ Other Non-current Liabilities	67.3	840.8	840.8
Non-current Liabilities	156.1	1,021.1	1,021.1
+ Borrowings — Current	13.7	73.0	73.0
+ Trade Payables	642.8	602.2	602.2
+ Other Current Financial Liab	140.6	141.3	141.3
Current Financial Liabilities	797.0	816.4	816.4
+ Provisions — Current	57.2	65.4	65.4
+ Current Tax Liabilities	0.4	8.9	8.9
+ Other Current Liabilities	39.1	204.0	204.0
Current Liabilities	893.7	1,094.8	1,094.8
Total Liabilities	1,049.8	2,115.8	2,115.8
Total Equity & Liabilities	4,113.4	5,447.0	5,447.0
Trade Payables — MSME split
+ Dues to Micro & Small — Current	77.2	88.0	88.0
+ Dues to Other Creditors — Current	565.6	514.2	514.2

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.